Skip to main content

UBS Group AG

Position in OBIO — Orchestra BioMed Holdings, Inc.

CIK 1610520 ZURICH, V8

Position in OBIO

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$213,817
+$166,554 QoQ
Shares Held
50,310
+341.7% QoQ
Ownership
0.084%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2023
12 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in OBIO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. OBIO ranks #331 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in OBIO

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $213,817 50,310
2025-12-31 $47,263 11,389
2025-09-30 $9,460 3,815
2025-06-30 $70,052 26,139
2025-03-31 $73,915 17,270
2024-12-31 $96,260 24,065
2024-09-30 $59,016 11,482
2024-06-30 $58,305 7,154
2024-03-31 $77,605 14,726
2023-12-31 $122,634 13,432
2023-09-30 $65,347 7,494
2023-06-30 $51,905 7,415